Extracellular Vesicles: New Players in the Mechanisms of Sepsis- and COVID-19-Related Thromboinflammation
Sepsis and COVID-19 patients often manifest an imbalance in inflammation and coagulation, a complex pathological mechanism also named thromboinflammation, which strongly affects patient prognosis. Extracellular vesicles (EVs) are nanoparticles released by cells into extracellular space that have a r...
Main Authors: | Martina Schiavello, Barbara Vizio, Ornella Bosco, Emanuele Pivetta, Filippo Mariano, Giuseppe Montrucchio, Enrico Lupia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/3/1920 |
Similar Items
-
Biomaterials for treating sepsis-induced thromboinflammation
by: Halle Lutz, et al.
Published: (2023-12-01) -
Platelet <i>Versus</i> Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?
by: Cédric Garcia, et al.
Published: (2022-04-01) -
Thrombopoietin participates in platelet activation in COVID-19 patients
by: Enrico Lupia, et al.
Published: (2022-11-01) -
Thromboinflammation in oncogynecological patients
by: E. V. Slukhanchuk, et al.
Published: (2022-11-01) -
The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies
by: Barry W. Festoff, et al.
Published: (2021-10-01)